These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20940181)

  • 41. Influence of lineage-specific amino acid dimorphisms in GyrA on Mycobacterium tuberculosis resistance to fluoroquinolones.
    Kim H; Nakajima C; Kim YU; Yokoyama K; Suzuki Y
    Jpn J Infect Dis; 2012; 65(1):72-4. PubMed ID: 22274162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Temporal changes in resistance mechanisms in colonizing Escherichia coli isolates with reduced susceptibility to fluoroquinolones.
    Han JH; Nachamkin I; Tolomeo P; Mao X; Bilker WB; Lautenbach E
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):491-6. PubMed ID: 23719087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.
    Lautenbach E; Fishman NO; Metlay JP; Mao X; Bilker WB; Tolomeo P; Nachamkin I
    J Infect Dis; 2006 Jul; 194(1):79-85. PubMed ID: 16741885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.
    Lázaro FG; Rodríguez-Tarazona RE; García-Rodríguez JA; Muñoz-Bellido JL
    Int J Antimicrob Agents; 2009 Sep; 34(3):252-4. PubMed ID: 19243922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro susceptibility of Actinobaculum schaalii to 12 antimicrobial agents and molecular analysis of fluoroquinolone resistance.
    Cattoir V; Varca A; Greub G; Prod'hom G; Legrand P; Lienhard R
    J Antimicrob Chemother; 2010 Dec; 65(12):2514-7. PubMed ID: 20952417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular characterization of high-level fluoroquinolone resistance in a clinical isolate of Haemophilus parainfluenzae.
    Rodríguez-Martínez JM; López-Hernández I; Pascual A
    J Antimicrob Chemother; 2011 Mar; 66(3):673-5. PubMed ID: 21127039
    [No Abstract]   [Full Text] [Related]  

  • 47. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK; Lee YS; Park YK; Kim BS
    Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
    Schurek KN; Adam HJ; Siemens CG; Hoban CJ; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2005 Oct; 56(4):769-72. PubMed ID: 16126779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella spp. from Norway and Sweden.
    Karah N; Poirel L; Bengtsson S; Sundqvist M; Kahlmeter G; Nordmann P; Sundsfjord A; Samuelsen Ø;
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):425-31. PubMed ID: 20226333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasmid-mediated QnrS2 determinant in an Aeromonas caviae isolate recovered from a patient with diarrhoea.
    Arias A; Seral C; Navarro F; Miró E; Coll P; Castillo FJ
    Clin Microbiol Infect; 2010 Jul; 16(7):1005-7. PubMed ID: 19863591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of the efflux pump QepA2 combined with chromosomally mediated mechanisms on quinolone resistance and bacterial fitness in Escherichia coli.
    Machuca J; Briales A; Díaz-de-Alba P; Martínez-Martínez L; Pascual Á; Rodríguez-Martínez JM
    J Antimicrob Chemother; 2015 Sep; 70(9):2524-7. PubMed ID: 26041043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in clinical strains of fluoroquinolone-resistant Shigella in Anhui, China.
    Hu LF; Li JB; Ye Y; Li X
    J Microbiol; 2007 Apr; 45(2):168-70. PubMed ID: 17483803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.
    Okumura R; Hirata T; Onodera Y; Hoshino K; Otani T; Yamamoto T
    J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone-resistant Streptococcus pneumoniae.
    Alonso R; Galimand M; Courvalin P
    J Antimicrob Chemother; 2004 Apr; 53(4):682-3. PubMed ID: 15014061
    [No Abstract]   [Full Text] [Related]  

  • 55. [Analysis of point mutations in the ygeD, gyrA and parC genes in fluoroquinolones resistant clinical isolates of Chlamydia trachomatis].
    Misiurina OIu; Shipitsina EV; Finashutina IuP; Lazarev VN; Akopian TA; Savicheva AM; Govorun VM
    Mol Gen Mikrobiol Virusol; 2004; (3):3-7. PubMed ID: 15354934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of plasmid-mediated quinolone resistance qnr genes in poultry and swine clinical isolates of Escherichia coli.
    Yue L; Jiang HX; Liao XP; Liu JH; Li SJ; Chen XY; Chen CX; Lü DH; Liu YH
    Vet Microbiol; 2008 Dec; 132(3-4):414-20. PubMed ID: 18573620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A fluoroquinolone-resistant Escherichia coli clinical isolate without quinolone resistance-determining region mutations found in Japan.
    Sato T; Yokota S; Uchida I; Okubo T; Ishihara K; Fujii N; Tamura Y
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3964-5. PubMed ID: 21670180
    [No Abstract]   [Full Text] [Related]  

  • 58. Relationships between mutant prevention concentrations and mutation frequencies against enrofloxacin for avian pathogenic Escherichia coli isolates.
    Ozawa M; Asai T
    J Vet Med Sci; 2013; 75(6):709-13. PubMed ID: 23328636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluoroquinolone resistance in Ureaplasma parvum in the United States.
    Duffy L; Glass J; Hall G; Avery R; Rackley R; Peterson S; Waites K
    J Clin Microbiol; 2006 Apr; 44(4):1590-1. PubMed ID: 16597903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.